RA
Raphael Pharmaceutical Inc.
RAPH · OTC
$1.40 +0.00% (+$0.00)
Market Cap $28.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 50.33%
ROA 14,000.00%
Debt
0 /100
High Int. coverage -17.49x
Current ratio 0.00x
Debt/Assets N/A
Stability
1 /100
Unstable Profitable years 0
Beta 1.90x
EPS volatility 94.94%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RAPH
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Shlomo Pilo
Employees
0
Headquarters
Jaffa